Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation
Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the clinical equivalence of the test formulation
of Linaclotide compared to the marketed formulation LINZESS® in patients with Chronic
Idiopathic Constipation, and to evaluate the efficacy and safety of the test formulation of
Linaclotide in the treatment of Chronic Idiopathic Constipation.